Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 31994R2701

Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

OJ L 287, 8.11.1994, p. 7–17 (ES, DA, DE, EL, EN, FR, IT, NL, PT)

⏵This document has been published in a special edition(s) (FI, SV, CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO)

Legal status of the document No longer in force, Date of end of validity: 05/07/2009; Implicitly repealed by 32009R0470

ELI: http://data.europa.eu/eli/reg/1994/2701/oj

8.11.1994   

EN

Official Journal of the European Communities

L 287/7

COMMISSION REGULATION (EC) NO 2701/94

of 7 November 1994

amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 1430/94 (2), and in particular Articles 6, 7 and 8 thereof,

Whereas, since the adoption of the Regulation, the Annexes have been amended a number of times; whereas, by reason of their number, their complexity and their dispersal among various Official Journals of the European Communities, the texts are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, they should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the adaptation to technical progress of directives on the removal of technical barriers to trade in the veterinary medicinal products sector,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes I, II, III and IV to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

Article 2

This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 November 1994.

For the Commission

Martin BANGEMANN

Member of the Commission

(1)  OJ No L 224, 18. 8. 1990, p. 1.

(2)  OJ No L 156, 23. 6. 1994, p. 6.

ANNEX

‘

ANNEX I

List of pharmacologically active substances for which maximum residue limits have been fixed

1.

Anti-infectious agents

1.1.

Chemotherapeutics

1.1.1.

Sulfonamides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

All substances belonging to the sulfonamide group

Parent drug

All food producing species

100 μg/kg

Muscle, liver, kidney, fat

The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

1.2.

Antibiotics

1.2.1.

Penicillins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.1.1.

Benzylpenicillin

Benzylpenicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

 

4 μg/kg

Milk

 

1.2.1.2.

Ampicillin

Ampicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

 

4 μg/kg

Milk

 

1.2.1.3.

Amoxicillin

Amoxicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

 

4 μg/kg

Milk

 

1.2.1.4.

Oxacillin

Oxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

 

30 μg/kg

Milk

 

1.2.1.5.

Cloxacillin

Cloxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

 

30 μg/kg

Milk

 

1.2.1.6.

Dicloxacillin

Dicloxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

 

30 μg/kg

Milk

 

1.2.2.

Cephalosporins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.2.1.

Cefquinome

Cefquinome

Bovine

200 μg/kg

Kidney

 

100 μg/kg

Liver

 

50 μg/kg

Muscle

 

50 μg/kg

Fat

 

1.2.3.

Quinolones

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.3.1.

Enrofloxacin

Sum of enrofloxacin and ciprofloxacin

Bovine, porcine, poultry

30 μg/kg

Muscle, liver, kidney

 

1.2.4.

Macrolides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.4.1. Tilmicosin

Tilmicosin

Bovine

1 000 μg/kg

Liver, kidney

 

50 μg/kg

Muscle, fat

 

2.

Antiparasitic agents

2.1.

Agents acting against endoparasites

2.1.1.

Avermectins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.1.1.

Ivermectin

22,23- Dihydroavermectin B1a

Bovine

100 μg/kg

Liver

 

40 μg/kg

Fat

 

Porcine

15 μg/kg

Liver

 

Ovine

20 μg/kg

Fat

 

Equidae

2.1.1.2.

Abamectin

Avermectin B1a

Bovine

20 μg/kg

Liver

 

10 μg/kg

Fat

 

2.1.1.3.

Doramectin

Doramectin

Bovine

15 μg/kg

Liver

 

25 μg/kg

Fat

 

2.1.2

Salicylanilides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.2.1.

Closantel

Closantel

Bovine

1 000 μg/kg

Muscle, liver

 

3 000 μg/kg

Kidney, fat

 

Ovine

1 500 μg/kg

Muscle, liver

 

5 000 μg/kg

Kidney, fat

 

2 000 μg/kg

 

 

ANNEX II

List of substances not subject to maximum residue limits

1.

Inorganic chemicals

Pharmacologically active substance(s)

Animal species

Other provisions

1.1.

Hydrogen peroxide

Fish

 

1.2.

Sulphur

Bovine

 

Porcine

 

Ovine

 

Caprine

 

Equidae

 

1.3.

Iodine and iodine inorganic compounds including:

—

Sodium and potassium — iodide

—

Sodium and potassium — iodate

—

Iodophors including polyvinylpyrrolidone — iodine

All food producing species

 

1.4.

Sodium chlorite

Bovine

For tropical use only

2.

Organic compounds

Pharmacologically active substance(s)

Animal species

Others provisions

2.1.

Etiproston tromethamine

Bovine

 

Porcine

 

2.2.

Ketanserin tartrate

Equidae

 

2.3.

Fertirelin acetate

Bovine

 

2.4.

Human menopausal urinary gonadotrophin

Bovine

 

2.5.

Lactic acid

All food producing species

 

2.6.

Melatonin

Ovine

 

Caprine

 

2.7.

Iodine organic compounds

—

Iodoform

All food producing species

 

2.8.

Acetyl cysteine

All food producing species

 

ANNEX III

List of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed

1.

Anti-infectious agents

1.1.

Chemotherapeutics

1.1.1.

Sulfonamides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

All substances belonging to the sulfonamide group

Parent drug

Bovine, ovine, caprine

100 μg/kg

Milk

Provisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

1.1.2.

Diamino pyrimidine derivates

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.2.1.

Trimethoprim

Trimethoprim

All food producing species

50 μg/kg

Muscle, liver, kidney, fat, milk

Provisional MRL expires on 1. 1. 1996

1.1.3.

Nitrofurans

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.3.1.

Furazolidone

All residues with intact 5-nitro structure

All food producing species

5 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 7. 1995

1.1.4.

Nitroimidazoles

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.4.1.

Dimetridazole

All residues with intact nitroimidazole structure

All food producing species

10 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 1. 1995

1.2.

Antibiotics

1.2.1.

Tetracyclines

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

All substances belonging to the tetracycline group

Parent drug

All food producing species

600 μg/kg

Kidney

Provisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated

300 μg/kg

Liver

200 μg/kg

Eggs

100 μg/kg

Muscle

100 μg/kg

Milk

1.2.2.

Macrolides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.2.1.

Spiramycin

Spiramycin

Bovine, porcine

300 μg/kg

Liver,

Provisional MRLs expire on 1. 7. 1995. The MRLs for liver, kidney and muscle apply to both the bovine and porcine species

200 μg/kg

Kidney,

50 μg/kg

Muscle

Bovine

150 μg/kg

Milk

1.2.2.2.

Tylosin

Bovine

100 μg/kg

Muscle, liver, kidney

Provisional MRLs expire on 1. 7. 1995

Porcine

 

 

Poultry

 

 

Bovine

50 μg/kg

Milk

1.2.3.

Thiamphenicol and related compounds

Pharmacologically active substance(s)

Market residue

Animal species

MRLs

Target tissues

Other provisions

1.2.3.1.

Thiamphenicol

Thiamphenicol

Bovine

Poultry

40 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 1. 1996

2.

Antiparasitic agents

2.1.

Agents acting against endo-parasites

2.1.1.

Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.1.1.

Febantel

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.2.

Fenbendazole

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.3.

Oxfendazole

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.4.

Albendazole

Sum of albendazole and metabolites which are measured as 2-amino-benzimidazole sulphone

Bovine

100 μg/kg

Muscle, fat, milk,

Provisional MRLs expire on 1. 1. 1996

Ovine

500 μg/kg

Kidney

 

1 000 μg/kg

Liver

2.1.1.5.

Thiabendazole

Sum of thiabendazole and 5-hydroxythiabendazole

Bovine

100 μg/kg

Muscle, liver, kidney, fat, milk

Provisional MRLs expire on 1. 1. 1996

Ovine

 

Caprine

 

2.1.1.6.

Triclabendazole

Sum of extractable residues that may be oxidized to ketotriclabendazole

Bovine

150 μg/kg

Muscle, liver, kidney

Provisional MRLs expire on 1. 7. 1995

Ovine

50 μg/kg

Fat

2.1.1.7.

Flubendazole

Flubendazole

Poultry

500 μg/kg

Liver,

Provisional MRLs expire on 1. 1. 1996

Game birds

200 μg/kg

Muscle,

400 μg/kg

Eggs

Porcine

10 μg/kg

Muscle, liver, kidney, fat

2.1.1.8.

Oxibendazole

Oxibendazole

Bovine

Ovine

100 μg/kg

Muscle, liver, kidney, fat

Provisional MRLs expire on 1. 1. 1996

 

50 μg/kg

Milk

Porcine

Equidae

100 μg/kg

Muscle, liver, kidney, fat

2.1.2.

Tetra-hydro-imidazoles (imidazolthiazoles)

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.2.1.

Levamisole

Levamisole

All food producing species

10 μg/kg

Musle, liver, kidney, fat, milk

Provisional MRL expires on 1. 1. 1995

2.2.

Agents acting against ectoparasites

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.2.1.

Amitraz

Sum of amitraz and metabolites which are measured as 2,4-dimethylaniline

Porcine

50 μg/kg

Muscle

Provisional MRLs expire on 1. 7. 1996.

200 μg/kg

Kidney, liver

3.

Agents acting on the nervous system

3.1.

Agents acting on the central nervous system

3.1.1.

Butyrophenone tranquilizers

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

3.1.1.1.

Azaperone

Azaperol

All food producing species

100 μg/kg

Kidney

Provisional MRLs expire on 1. 1. 1996

50 μg/kg1

Liver, muscle, fat

3.2.

Agents acting on the autonomic nervous system

3.2.1.

Anti-adrenergics

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

3.2.1.1.

Carazolol

Carazolol

All food producing species

30 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995

5 μg/kg

Kidney, muscle, fat

ANNEX IV

List of pharmacologically active substances for which no maximum levels can be fixed

1.

Nitrofurans, except furazolidone (see Annex III)

2.

Ronidazole

3.

Dapsone

4.

Chloramphenicol
’
Top